Price $81.47 |
Market Cap
11.59B
|
Sector Health Care |
Div. Growth
-
|
|
P/E
58.5
|
P/B
12.17
|
P/S
5.56
|
Dividend %
0.20%
|
|
P/CF
-
|
P/FCF
42.7
|
Op. Cash Flow
395.2K
|
FCF
1.8
|
|
Op. Margin
15.20%
|
Net Margin
9.60%
|
ROE
21.60%
|
ROI
10.20%
|
|
ROA
6.90%
|
EPS Growth
16.70%
|
Current Ratio
2.4
|
Debt/Equity
87.60%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Bausch Health Companies Inc (BHC) | $29.54 | - | - | 10.52B | Strong Buy |
| Sonoma Pharmaceuticals Inc (SNOA) | $6.53 | - | - | 15.2M | Strong Buy |
| Genesis Healthcare Inc (GENN) | $0.25 | - | - | 53.6M | Strong Buy |
| IntriCon Corporation (IIN) | $23.80 | - | - | 200M | Strong Buy |
| Recro Pharma Inc (REPH) | $1.80 | - | - | 97.6M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
